| Literature DB >> 28813677 |
Antonella De Luca1, Marilena Pariano1, Barbara Cellini1, Claudio Costantini1, Valeria Rachela Villella2, Shyam Sushama Jose3, Melissa Palmieri1, Monica Borghi1, Claudia Galosi1, Giuseppe Paolicelli1, Luigi Maiuri4, Jan Fric3, Teresa Zelante5.
Abstract
The interleukin 17 (IL-17) cytokine and receptor family is central to antimicrobial resistance and inflammation in the lung. Mice lacking IL-17A, IL-17F, or the IL-17RA subunit were compared with wild-type mice for susceptibility to airway inflammation in models of infection and allergy. Signaling through IL-17RA was required for efficient microbial clearance and prevention of allergy; in the absence of IL-17RA, signaling through IL-17RC on epithelial cells, predominantly by IL-17F, significantly exacerbated lower airway Aspergillus or Pseudomonas infection and allergic airway inflammation. In contrast, following infection with the upper respiratory pathogen Staphylococcus aureus, the IL-17F/IL-17RC axis mediated protection. Thus, IL-17A and IL-17F exert distinct biological effects during pulmonary infection; the IL-17F/IL-17RC signaling axis has the potential to significantly worsen pathogen-associated inflammation of the lower respiratory tract in particular, and should be investigated further as a therapeutic target for treating pathological inflammation in the lung.Entities:
Keywords: ABPA; IL-17F/IL-17RC axis; Th17 immunity; allergy; respiratory infections
Mesh:
Substances:
Year: 2017 PMID: 28813677 DOI: 10.1016/j.celrep.2017.07.063
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423